Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07257042 · ClinicalTrials.gov registry record · Phase 3
Oothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste in Reducing Dentinal Hypersensitivity
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT07257042 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 80 participants.
The verdict
NCT07257042, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The objective of this study is to assess clinical efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) to provide dental hypersensitivity relief (tactile and air blast) in comparison to Colgate Cavity Protection Toothpaste (Colgate-Palmolive Company, New York, NY, USA) over an eight-week period.
Interventions
- DRUG Colgate Cavity Protection Toothpaste
- DRUG Toothpaste containing 8% Arginine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2025-11-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07257042
The ClinicalTrials.gov registry entry for NCT07257042 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Colgate Cavity Protection Toothpaste is the first listed.
NCT07257042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07257042 about?
NCT07257042 is a clinical study titled "Oothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste in Reducing Dentinal Hypersensitivity". The objective of this study is to assess clinical efficacy of a toothpaste containing 8% arginine (Colgate-Palmolive Company, New York, NY, USA) to provide dental hypersensitivity relief (tactile and air blast) in comparison to Colgate Cavity Protection Toothpaste (Colgate-Palmolive Company, New Yor...
What is the current status of trial NCT07257042?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2025-07-14. Estimated completion is 2025-11-04.
What interventions are being tested in trial NCT07257042?
The interventions under investigation include: Colgate Cavity Protection Toothpaste (DRUG), Toothpaste containing 8% Arginine (DRUG).
Who is sponsoring clinical trial NCT07257042?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.